Medirom Historical Balance Sheet
MRM Stock | USD 0.92 0.01 1.08% |
Trend analysis of Medirom Healthcare Technologies balance sheet accounts such as Total Current Liabilities of 3.2 B provides information on Medirom Healthcare's total assets, liabilities, and equity, which is the actual value of Medirom Healthcare to its prevalent stockholders. By breaking down trends over time using Medirom Healthcare balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Medirom Healthcare latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Medirom Healthcare is a good buy for the upcoming year.
Medirom Healthcare Inventory |
|
Medirom |
About Medirom Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Medirom Healthcare at a specified time, usually calculated after every quarter, six months, or one year. Medirom Healthcare Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Medirom Healthcare and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Medirom currently owns. An asset can also be divided into two categories, current and non-current.
Medirom Healthcare Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of Medirom Healthcare assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Medirom Healthcare books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on Medirom Healthcare balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Medirom Healthcare Technologies are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Most accounts from Medirom Healthcare's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Medirom Healthcare current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medirom Healthcare Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. At this time, Medirom Healthcare's Retained Earnings are very stable compared to the past year. As of the 3rd of February 2025, Accounts Payable is likely to grow to about 166.3 M, while Short and Long Term Debt Total is likely to drop about 2.9 B.
2022 | 2023 | 2024 | 2025 (projected) | Short and Long Term Debt Total | 2.5B | 3.6B | 4.2B | 2.9B | Total Assets | 6.7B | 6.8B | 7.9B | 6.3B |
Medirom Healthcare balance sheet Correlations
Click cells to compare fundamentals
Medirom Healthcare Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Medirom Healthcare balance sheet Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Total Assets | 5.7B | 5.8B | 6.7B | 6.8B | 7.9B | 6.3B | |
Short Long Term Debt Total | 1.9B | 2.8B | 2.5B | 3.6B | 4.2B | 2.9B | |
Other Current Liab | 1.7B | 1.9B | 2.6B | 1.6B | 1.9B | 1.6B | |
Total Current Liabilities | 2.7B | 3.2B | 3.6B | 3.6B | 4.1B | 3.2B | |
Total Stockholder Equity | 491.3M | (208.3M) | (59.4M) | 210.9M | 189.8M | 122.3M | |
Property Plant And Equipment Net | 1.8B | 2.2B | 2.4B | 2.5B | 2.9B | 2.4B | |
Current Deferred Revenue | 442.4M | 104.2M | 89.0M | 512.0M | 460.8M | 287.1M | |
Net Debt | 463.8M | 2.4B | 1.9B | 3.5B | 4.1B | 2.3B | |
Retained Earnings | (1.7B) | (2.7B) | (2.5B) | 80.3M | 72.2M | 75.9M | |
Accounts Payable | 67.0M | 230.9M | 207.6M | 137.7M | 158.4M | 166.3M | |
Cash | 1.4B | 370.6M | 605.5M | 106.3M | 95.7M | 90.9M | |
Non Current Assets Total | 3.6B | 4.4B | 4.4B | 5.1B | 5.9B | 4.5B | |
Non Currrent Assets Other | 1.6B | 107.2M | 1.0B | 1.1B | 956.5M | 749.7M | |
Long Term Debt | 668.4M | 746.6M | 1.1B | 1.1B | 1.2B | 753.3M | |
Cash And Short Term Investments | 1.5B | 397.1M | 606.0M | 106.8M | 96.2M | 91.4M | |
Net Receivables | 148.5M | 855.3M | 534.7M | 621.9M | 559.7M | 476.9M | |
Good Will | 150.7M | 600.3M | 539.5M | 484.6M | 557.2M | 351.5M | |
Common Stock Shares Outstanding | 4.0M | 4.9M | 5.5M | 5.2M | 5.9M | 5.4M | |
Short Term Investments | 38.5M | 32.5M | 26.5M | 500K | 450K | 427.5K | |
Liabilities And Stockholders Equity | 5.7B | 5.8B | 6.7B | 6.8B | 7.9B | 6.3B | |
Non Current Liabilities Total | 2.6B | 2.8B | 3.2B | 3.1B | 3.5B | 2.9B | |
Capital Lease Obligations | 1.7B | 1.9B | 2.0B | 2.1B | 2.4B | 2.1B | |
Inventory | 8.0M | 18.7M | 114.1M | 140.0M | 161.0M | 169.0M | |
Other Current Assets | 458.5M | 111.2M | 1.1B | 890.0M | 1.0B | 1.1B | |
Other Stockholder Equity | 710.3M | 1.0B | 1.3B | 110.6M | 127.2M | 120.8M | |
Total Liab | 5.2B | 6.0B | 6.8B | 6.6B | 7.6B | 6.1B | |
Net Invested Capital | 1.3B | 700.5M | 1.2B | 1.8B | 2.0B | 1.2B | |
Long Term Investments | 14.0M | 2.4M | 53.0M | 81.5M | 93.8M | 46.9M | |
Property Plant And Equipment Gross | 183.1M | 2.4B | 2.6B | 2.8B | 3.3B | 2.3B | |
Short Long Term Debt | 221.1M | 162.3M | 99.2M | 500.4M | 450.4M | 235.8M | |
Total Current Assets | 2.1B | 1.4B | 2.4B | 1.8B | 2.0B | 1.8B | |
Capital Stock | 595.1M | 1.2B | 1.2B | 20M | 23M | 21.9M | |
Non Current Liabilities Other | 348.4M | 25.2M | 335.0M | 271.7M | 312.5M | 182.0M | |
Net Working Capital | 428.3M | (1.8B) | (1.3B) | (1.8B) | (1.6B) | (1.7B) | |
Short Term Debt | 900.6M | 917.5M | 868.9M | 1.3B | 1.1B | 827.8M | |
Intangible Assets | 97.6M | 391.0M | 403.7M | 920.7M | 1.1B | 1.1B |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medirom Healthcare Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medirom Healthcare. If investors know Medirom will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medirom Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.582 | Earnings Share (0.15) | Revenue Per Share | Quarterly Revenue Growth (0.06) | Return On Assets |
The market value of Medirom Healthcare is measured differently than its book value, which is the value of Medirom that is recorded on the company's balance sheet. Investors also form their own opinion of Medirom Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Medirom Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medirom Healthcare's market value can be influenced by many factors that don't directly affect Medirom Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Medirom Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Medirom Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medirom Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.